Mesa Laboratories, Inc.
MLAB
$107.64
$1.601.51%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 249.73M | 249.13M | 247.54M | 245.26M | 242.35M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 249.73M | 249.13M | 247.54M | 245.26M | 242.35M |
| Cost of Revenue | 89.38M | 90.86M | 93.06M | 92.82M | 91.34M |
| Gross Profit | 160.34M | 158.27M | 154.48M | 152.44M | 151.01M |
| SG&A Expenses | 117.82M | 119.45M | 117.09M | 117.22M | 116.97M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 227.25M | 230.62M | 230.31M | 230.22M | 228.08M |
| Operating Income | 22.48M | 18.51M | 17.23M | 15.04M | 14.27M |
| Income Before Tax | 9.36M | 12.01M | 14.07M | 7.26M | 9.07M |
| Income Tax Expenses | 4.56M | 5.30M | 10.33M | 8.83M | 9.69M |
| Earnings from Continuing Operations | 4.80 | 6.71 | 3.73 | -1.57 | -0.62 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 4.80M | 6.71M | 3.73M | -1.57M | -620.00K |
| EBIT | 22.48M | 18.51M | 17.23M | 15.04M | 14.27M |
| EBITDA | 45.44M | 41.78M | 42.25M | 39.84M | 39.29M |
| EPS Basic | 0.86 | 1.23 | 0.67 | -0.30 | -0.12 |
| Normalized Basic EPS | 1.05 | 1.37 | 1.60 | 0.83 | 1.09 |
| EPS Diluted | 0.84 | 1.20 | 0.64 | -0.32 | -0.14 |
| Normalized Diluted EPS | 1.03 | 1.35 | 1.58 | 0.81 | 1.07 |
| Average Basic Shares Outstanding | 22.25M | 22.05M | 21.95M | 21.85M | 21.75M |
| Average Diluted Shares Outstanding | 22.40M | 22.20M | 22.09M | 21.96M | 21.89M |
| Dividend Per Share | 0.64 | 0.64 | 0.64 | 0.64 | 0.64 |
| Payout Ratio | 73.63% | 52.49% | 93.97% | -222.26% | -560.97% |